Oral Tranexamic Acid Enhances the Efficacy of Low-Fluence 1064-Nm Quality-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment for Melasma in Koreans: A Randomized, Prospective Trial

Abstract

Oral TA may prove a safe and efficient treatment option for melasma in combination with low-fluence QSNY laser therapy.

Role of Oral Tranexamic Acid in Treating Patients of Melasma in A Charity Hospital of Lahore

“…Our study showed very few side effects with low dose of tranexamic acid like abdominal cramps, oligomenorrhoea in 3 patients each and rest of the patients had no side effects which are almost similar to the study done in Lahore by Safoora et al 2 and some other studies 18,19,20 . So, the results of our study are somewhat similar to the results attained in other studies.…”

Role of Oral Tranexamic Acid in Treating Patients of Melasma in A Charity Hospital of Lahore

“…Our study showed very few side effects with low dose of tranexamic acid like abdominal cramps, oligomenorrhoea in 3 patients each and rest of the patients had no side effects which are almost similar to the study done in Lahore by Safoora et al 2 and some other studies 18,19,20 . So, the results of our study are somewhat similar to the results attained in other studies.…”

Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q‐switched fractional 1064‐nm Nd:YAG laser: A blinded RCT and follow‐up

“…Sadako was the first one who introduces TA for treatment of melasma, in 1979. This was a coincidental finding that was identified during the study on the therapeutic effect of TA on urticaria, and then, a study was conducted to determine the effect of this drug on melasma 3 …”

Efficacy and safety of laser‐related therapy for melasma: A systematic review and network meta‐analysis

“…Then, by screening the titles and abstracts, we further eliminated 793 studies. Ultimately, 39 randomized clinical trials 12,18–55 were included in the network meta‐analysis. The flowchart of screening and selection is depicted in Figure 1.…”

Role of Oral Tranexamic Acid in Treating Patients of Melasma in A Charity Hospital of Lahore

“…Our study showed very few side effects with low dose of tranexamic acid like abdominal cramps, oligomenorrhoea in 3 patients each and rest of the patients had no side effects which are almost similar to the study done in Lahore by Safoora et al 2 and some other studies 18,19,20 . So, the results of our study are somewhat similar to the results attained in other studies.…”

Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q‐switched fractional 1064‐nm Nd:YAG laser: A blinded RCT and follow‐up

“…Sadako was the first one who introduces TA for treatment of melasma, in 1979. This was a coincidental finding that was identified during the study on the therapeutic effect of TA on urticaria, and then, a study was conducted to determine the effect of this drug on melasma 3 …”

Efficacy and safety of laser‐related therapy for melasma: A systematic review and network meta‐analysis

“…Then, by screening the titles and abstracts, we further eliminated 793 studies. Ultimately, 39 randomized clinical trials 12,18–55 were included in the network meta‐analysis. The flowchart of screening and selection is depicted in Figure 1.…”

Role of Oral Tranexamic Acid in Treating Patients of Melasma in A Charity Hospital of Lahore

“…Our study showed very few side effects with low dose of tranexamic acid like abdominal cramps, oligomenorrhoea in 3 patients each and rest of the patients had no side effects which are almost similar to the study done in Lahore by Safoora et al 2 and some other studies 18,19,20 . So, the results of our study are somewhat similar to the results attained in other studies.…”

Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q‐switched fractional 1064‐nm Nd:YAG laser: A blinded RCT and follow‐up

“…Sadako was the first one who introduces TA for treatment of melasma, in 1979. This was a coincidental finding that was identified during the study on the therapeutic effect of TA on urticaria, and then, a study was conducted to determine the effect of this drug on melasma 3 …”

Efficacy and safety of laser‐related therapy for melasma: A systematic review and network meta‐analysis

“…Then, by screening the titles and abstracts, we further eliminated 793 studies. Ultimately, 39 randomized clinical trials 12,18–55 were included in the network meta‐analysis. The flowchart of screening and selection is depicted in Figure 1.…”